Flow Proportional Pressure Support in Volunteers

Flow Proportional Pressure Support as a New Mode of Spontaneous Breathing Assist - Evaluation of Objective and Subjective Measured Data in Volunteers

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00866541

Enrollment

Registered

2009-03-20

Start date

2009-01-31

Completion date

Unknown

Last updated

2009-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

resistance, flow proportional pressure support, pressure support ventilation, volunteers, assistant breathing, breathing comfort and objective breathing data

Brief summary

Flow proportional pressure support (FPPS) is a new mode of spontaneous breathing assistance. In patients with increased respiratory resistance the role of FPPS in comparison with the pressure support assist breathing mode is still unclear. In this study the investigators evaluate objective and subjective measured data in healthy volunteers with artificial increased resistance and FPPS breathing assistance.

Interventions

DEVICEartificial increased resistance (flow proportional pressure support)

respiratory resistance is increased by interpose of an artificial resistance tool in the in- and expiratory airways of the mechanical respirator

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

BASIC_SCIENCE

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* age over 18 years * ASA I and II

Exclusion criteria

* refusal of written informed consent * chronic respiratory or cardiac diseases

Design outcomes

Primary

Measure	Time frame
pressure support	3 years

Countries

Germany

Contacts

Primary ContactDaniel Steinmann, MD

daniel.steinmann@uniklinik-freiburg.de0049 761 270 2329

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026